In addition to anti-BTLA Ab, chemotherapy combined with other BTLA-related inhibitors such as LY294002 (AKT inhibitor) or BP-1-102 (STAT3 inhibitor) can generate potent anti-tumor effects compared to chemotherapy alone (Fig. 3f). Here, BTLA is linked to neoplasm.